How many insider trades does FilingIQ track for NXGL?

FilingIQ tracks 97 Form 4 insider transactions for NXGL (NEXGEL, INC.), covering filings from Dec 27, 2021 onwards. 6 of those were filed in the last 90 days.

Are NXGL insiders net buyers or net sellers?

Across the full Form 4 history for NXGL, 67 transactions (69%) were open-market purchases and 26 (27%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does NXGL insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is NXGL in?

NEXGEL, INC. (NXGL) is classified in the Healthcare sector, specifically Medical Instruments & Supplies, with a current market capitalisation of $5.50M.

NXGL insider trading

NasdaqCM Healthcare

NEXGEL, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

69% / 27%

Market cap

$5.50M

About NEXGEL, INC.

NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also developing NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Lumagel Beauty, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.

Company website: nexgel.com

NXGL insider activity at a glance

FilingIQ has scored 97 insider transactions for NXGL since Dec 27, 2021. The most recent filing in our index is dated May 14, 2026.

Across the full history, 67 open-market purchases and 26 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on NXGL insider trades is 56.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live NXGL trades on FilingIQ Raw filings on SEC EDGAR

Latest NXGL Form 4 filings

Drapczuk Adam E III Chief Financial Officer

P Mar 1, 2024

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,147

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 185

Adaptive Biotechnologies Corp

GH 173

Guardant Health, Inc.

ISRG 169

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for NXGL?: FilingIQ tracks 97 Form 4 insider transactions for NXGL (NEXGEL, INC.), covering filings from Dec 27, 2021 onwards. 6 of those were filed in the last 90 days.
Are NXGL insiders net buyers or net sellers?: Across the full Form 4 history for NXGL, 67 transactions (69%) were open-market purchases and 26 (27%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does NXGL insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is NXGL in?: NEXGEL, INC. (NXGL) is classified in the Healthcare sector, specifically Medical Instruments & Supplies, with a current market capitalisation of $5.50M.

Methodology & sources

Every NXGL insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.